Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Commentary/Editorials
Commentary/Editorials
Management of immune checkpoint therapy for patients with cancer in the face of COVID-19
Chen
Shen
,
Qianru
Li
,
Yongchang
Wei
,
Yuting
Li
,
Jun
Li
,
Juan
Tao
Journal for ImmunoTherapy of Cancer
Dec 2020,
8
(2)
e001593;
DOI:
10.1136/jitc-2020-001593
Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy
Agnieszka Beata
Malczewski
,
Severine
Navarro
,
Jermaine IG
Coward
,
Natkunam
Ketheesan
Journal for ImmunoTherapy of Cancer
Oct 2020,
8
(2)
e001383;
DOI:
10.1136/jitc-2020-001383
Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy
Ena
Wang
,
Alessandra
Cesano
,
Lisa H
Butterfield
,
Francesco
Marincola
Journal for ImmunoTherapy of Cancer
Oct 2020,
8
(2)
e001619;
DOI:
10.1136/jitc-2020-001619
Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity
Karla A
Lee
,
Heather
Shaw
,
Véronique
Bataille
,
Paul
Nathan
Journal for ImmunoTherapy of Cancer
Oct 2020,
8
(2)
e000577;
DOI:
10.1136/jitc-2020-000577
Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
Fei
Zhou
,
Wencheng
Zhao
,
Xiaomei
Gong
,
Shengxiang
Ren
,
Chunxia
Su
,
Tao
Jiang
,
Caicun
Zhou
Journal for ImmunoTherapy of Cancer
Sep 2020,
8
(2)
e001300;
DOI:
10.1136/jitc-2020-001300
Tracking the tail
Alex
Friedlaender
,
Stephen V
Liu
,
Alfredo
Addeo
Journal for ImmunoTherapy of Cancer
Sep 2020,
8
(2)
e000971;
DOI:
10.1136/jitc-2020-000971
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
Ernesto
Rossi
,
Giovanni
Schinzari
,
Giampaolo
Tortora
Journal for ImmunoTherapy of Cancer
Jul 2020,
8
(2)
e000952;
DOI:
10.1136/jitc-2020-000952
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
Madhuri
Koti
,
Alvaro
Morales
,
Charles H
Graham
,
David Robert
Siemens
Journal for ImmunoTherapy of Cancer
Jul 2020,
8
(2)
e001119;
DOI:
10.1136/jitc-2020-001119
Being “penny-wise but pound foolish” in cancer immunotherapy research: the urgent need for mouse cancer models to reflect human modifying factors
William J.
Murphy
Journal for ImmunoTherapy of Cancer
Dec 2016,
4
(1)
88;
DOI:
10.1186/s40425-016-0195-0
A quantum leap in cancer vaccines?
Eli
Gilboa
Journal for ImmunoTherapy of Cancer
Dec 2016,
4
(1)
87;
DOI:
10.1186/s40425-016-0192-3
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
next ›
last »
Special collections
COVID-19
(45)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(560)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(983)
Commentary/Editorials
(153)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(56)
Guidelines and Consensus Statements
(53)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(242)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(437)
Liquid Biopsies
(10)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(151)
Reviews
(245)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(5026)
Press releases
(2)
